Alzheimer’s Disease and Mild Cognitive Impairment, DMS48 Visual Memory Comparative Results.
Main Article Content
Abstract
Alzheimer's disease is known as a progressive neurological disorder that initially impacts memory, behavior and overall cognitive abilities; it is the widely most common cause of dementia, resulting from abnormal brain changes. While various factors can contribute to these changes, ageing is the most common cause. One of the first cognitive functions affected in early-stage Alzheimer's is episodic visual memory, which becomes noticeable in affected individuals. Aging also impacts cognitive abilities such as attention, perception, memory, and language, although not as severely as Alzheimer's disease. Mild Cognitive Impairment is a condition where individuals experience mild cognitive decline that exceeds what is expected for their age but is not severe enough to interfere with daily life. MCI typically involves memory, thinking, and judgment issues, but the changes are not significant enough to be classified as dementia. This study aims to differentiate between Alzheimer's disease and Mild Cognitive Impairment in terms of visual episodic memory using the DMS48.
Article Details
Copyright Notice
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
This allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal[cite: 2, 11].
The journal allows authors to deposit the Version of Record (published version) in an institutional or other repository of their choice without any embargo period.
References
2. Bansal, Nitin & Parle, Milind. (2014). Dementia: An Overview. Journal of Pharmaceutical Technology, Research and Management. 2. 29-45. 10.15415/jptrm.2014.21003.
3. Barbeau, Emmanuel & Tramoni, E. & Joubert, S. & Mancini, Julien & Ceccaldi, Mathieu & Poncet, M.. (2004). Evaluation de la mémoire de reconnaissance visuelle : Normalisation d'une nouvelle épreuve en choix forcé (DMS48) et utilité en neuropsychologie clinique. L'Évaluation des Troubles de la Mémoire. 85-101.
4. Bradfield NI. Mild Cognitive Impairment: Diagnosis and Subtypes. Clin EEG Neurosci. 2023 Jan;54(1):4-11. doi: 10.1177/15500594211042708. Epub 2021 Sep 22. PMID: 34549629.
5. Breijyeh Z, Karaman R. Comprehensive Review on Alzheimer's Disease: Causes and Treatment. Molecules. 2020 Dec 8;25(24):5789. doi: 10.3390/molecules25245789. PMID: 33302541; PMCID: PMC7764106.
6. Chang Wong E, Chang Chui H. (2022 Jun) Vascular Cognitive Impairment and Dementia. Continuum (Minneap Minn). 1;28(3):750-780. doi: 10.1212/CON.0000000000001124. PMID: 35678401; PMCID: PMC9833847.
7. Gagliardi G, Epelbaum S, Houot M, Bakardjian H, Boukadida L, Revillon M, Dubois B, Dalla Barba G, La Corte V; INSIGHT-preAD study group. Which Episodic Memory Performance is Associated with Alzheimer's Disease Biomarkers in Elderly Cognitive Complainers? Evidence from a Longitudinal Observational Study with Four Episodic Memory Tests (Insight-PreAD). J Alzheimers Dis. 2019 ;70(3) :811-824. doi: 10.3233/JAD-180966. PMID: 31282413.
8. Jahn H. Memory loss in Alzheimer's disease. Dialogues Clin Neurosci. 2013 Dec ;15(4) :445-54. doi: 10.31887/DCNS.2013.15.4/hjahn. PMID: 24459411; PMCID: PMC3898682.
9. Jongsiriyanyong S, Limpawattana P. Mild Cognitive Impairment in Clinical Practice: A Review Article. Am J Alzheimers Dis Other Demen. 2018 Dec;33(8):500-507.
10. Kumar A, Sidhu J, Lui F, Tsao JW. Alzheimer Disease. 2024 Feb 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 29763097
11. Marina Avila-Villanueva, Alberto Marcos Dolado, Jaime Gomez-Ramirez and Miguel Fernandez Blazquez, Brain Structural and Functional Changes in Cognitive Impairment Due to Alzheimer’s Disease, Frontiers in Psychology, 21 June 2022, doi : 10.3389/fpsyg.2022.886619.
12. Meléndez JC, Pitarque A, Delhom I, Real E, Abella M, Satorres E. A Longitudinal Study of Episodic and Semantic Autobiographical Memory in aMCI and Alzheimer's Disease Patients. Int J Environ Res Public Health. 2021 Jun 25;18(13):6849. doi: 10.3390/ijerph18136849. PMID: 34202299; PMCID: PMC8297234.
13. Patnode CD, Perdue LA, Rossom RC, Rushkin MC, Redmond N, Thomas RG, Lin JS. Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task Force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Feb. Report No.: 19-05257-EF-1. PMID: 32129963.
14. Petersen, R.C. (2004), Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine, 256: 183-194. https://doi.org/10.1111/j.1365-2796.2004.01388.x
15. Simon J, Bastin C. Mémoire épisodique dans la maladie d'Alzheimer - Déclin de la remémoration consciente et de la familiarité ? [Episodic memory in Alzheimer's disease: decline in recollection and familiarity?]. Med Sci (Paris). 2014 Aug-Sep;30(8-9):784-9. French. doi: 10.1051/medsci/20143008017. Epub 2014 Sep 1. PMID: 25174756.
16. ‘’What is dementia’’, 2024, Website source: https://www.alz.org/alzheimers-dementia/what-is-dementia.